381 related articles for article (PubMed ID: 35725926)
1. Radiotheranostics in oncology: current challenges and emerging opportunities.
Bodei L; Herrmann K; Schöder H; Scott AM; Lewis JS
Nat Rev Clin Oncol; 2022 Aug; 19(8):534-550. PubMed ID: 35725926
[TBL] [Abstract][Full Text] [Related]
2. Radiotheranostics in oncology: Making precision medicine possible.
Aboagye EO; Barwick TD; Haberkorn U
CA Cancer J Clin; 2023; 73(3):255-274. PubMed ID: 36622841
[TBL] [Abstract][Full Text] [Related]
3. Advances in Radioligand Theranostics in Oncology.
Lawal IO; Abubakar SO; Ndlovu H; Mokoala KMG; More SS; Sathekge MM
Mol Diagn Ther; 2024 May; 28(3):265-289. PubMed ID: 38555542
[TBL] [Abstract][Full Text] [Related]
4. [Trends of Radiotheranostics Research].
Hosono M
Gan To Kagaku Ryoho; 2022 Aug; 49(8):809-812. PubMed ID: 36046961
[TBL] [Abstract][Full Text] [Related]
5. An introduction to the clinical practice of theranostics in oncology.
Turner JH
Br J Radiol; 2018 Nov; 91(1091):20180440. PubMed ID: 30179054
[TBL] [Abstract][Full Text] [Related]
6. Radiotheranostics in Cancer Diagnosis and Management.
Jadvar H; Chen X; Cai W; Mahmood U
Radiology; 2018 Feb; 286(2):388-400. PubMed ID: 29356634
[TBL] [Abstract][Full Text] [Related]
7. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.
Burkett BJ; Bartlett DJ; McGarrah PW; Lewis AR; Johnson DR; Berberoğlu K; Pandey MK; Packard AT; Halfdanarson TR; Hruska CB; Johnson GB; Kendi AT
Radiol Imaging Cancer; 2023 Jul; 5(4):e220157. PubMed ID: 37477566
[TBL] [Abstract][Full Text] [Related]
8. Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation.
Sun J; Huangfu Z; Yang J; Wang G; Hu K; Gao M; Zhong Z
Adv Drug Deliv Rev; 2022 Nov; 190():114538. PubMed ID: 36162696
[TBL] [Abstract][Full Text] [Related]
9. [Radiotheranostics Based on Chemical Control of Radioactivity Pharmacokinetics].
Ono M
Yakugaku Zasshi; 2024; 144(3):291-297. PubMed ID: 38432939
[TBL] [Abstract][Full Text] [Related]
10. Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics.
Velikyan I; Eriksson O
Theranostics; 2020; 10(1):437-461. PubMed ID: 31903131
[TBL] [Abstract][Full Text] [Related]
11. Development of Diagnostic and Therapeutic Probes with Controlled Pharmacokinetics for Use in Radiotheranostics.
Ogawa K
Chem Pharm Bull (Tokyo); 2019; 67(9):897-903. PubMed ID: 31474726
[TBL] [Abstract][Full Text] [Related]
12. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer.
Herrero Álvarez N; Bauer D; Hernández-Gil J; Lewis JS
ChemMedChem; 2021 Oct; 16(19):2909-2941. PubMed ID: 33792195
[TBL] [Abstract][Full Text] [Related]
14. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges.
Salih S; Alkatheeri A; Alomaim W; Elliyanti A
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014472
[TBL] [Abstract][Full Text] [Related]
16. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.
Coll RP; Bright SJ; Martinus DKJ; Georgiou DK; Sawakuchi GO; Manning HC
Mol Imaging Biol; 2023 Dec; 25(6):991-1019. PubMed ID: 37845582
[TBL] [Abstract][Full Text] [Related]
17. [Radiotheranostics in endocrinology and oncoendocrinology].
Rumyanstsev RO
Probl Endokrinol (Mosk); 2021 Feb; 67(1):8-12. PubMed ID: 33586387
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.
Prior JO; Gillessen S; Wirth M; Dale W; Aapro M; Oyen WJG
Eur J Cancer; 2017 May; 77():127-139. PubMed ID: 28391026
[TBL] [Abstract][Full Text] [Related]
19. Biologicals as theranostic vehicles in paediatric oncology.
Niessen VJA; Wenker STM; Lam MGEH; van Noesel MM; Poot AJ
Nucl Med Biol; 2022; 114-115():58-64. PubMed ID: 36126433
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer.
Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR
Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]